MedTrace Logo

Immune Response to Hepatitis C Virus

NCT00165919 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-11-13

No results posted yet for this study

Summary

The purpose of the study is to investigate the immune response to hepatitis C virus to determine why some people clear the virus and others develop chronic infection. Changes in immune response once hepatitis C therapy is begun will also be examined. If patients are also HIV+, the effect of antiretroviral therapy on the recovery of hepatitis C immunity will be investigated.

Conditions

  • Hepatitis C
  • HIV Infections

Interventions

OTHER

None. Not a clinical trial. Specimens taken for basic research in laboratory.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Arash Grakoui, Ph.D. · Emory University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2005-09-30
Completion
2005-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165919 on ClinicalTrials.gov